OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.

The company’s first product- the InSpace™ System is indicated for Rotator Cuff syndrome as it alleviates pain in patients. The InSpace™ System has the CE mark and is commercially available in Europe. 

In the USA, the InSpace is an investigational device. Limited by Federal (or United States) law to investigational use. Exclusively for clinical investigations.

Type
Private
HQ
Caesarea, IL
Founded
2009
Size (employees)
29 (est)
OrthoSpace was founded in 2009 and is headquartered in Caesarea, IL
Report incorrect company information

Key People/Management at OrthoSpace

Itay Barnea

Itay Barnea

Chief Executive Officer
Avigail Hadar

Avigail Hadar

Chief Financial Officer
Yoav Meiraz

Yoav Meiraz

Chief Operating Officer
Ruthy Icekson

Ruthy Icekson

Director of Marketing
Elana Markovitz

Elana Markovitz

VP Clinical & Regulatory Affairs
Yair Penias

Yair Penias

Director Quality Assurance & Regulatory Affairs
Show more

OrthoSpace Office Locations

OrthoSpace has offices in Bengaluru, Vlaardingen, Viriat, Milano and in 10 other locations
Caesarea, IL (HQ)
7 Khalamish St
Macquarie Park, AU
85 Waterloo Rd
Viriat, FR
1663 Rue de Majornas
Kiel, DE
193 Werftstraße
Agia Paraskevi, GR
533 Leof. Mesogeion
Bengaluru, IN
24th Main Rd
Show all (14)
Report incorrect company information

OrthoSpace Financials and Metrics

Summary Metrics

Founding Date

2009

Total Funding

$15 m

Latest funding size

$7 m

Time since last funding

a year ago

Investors

OrthoSpace's latest funding round in December 2016 was reported to be $7 m. In total, OrthoSpace has raised $15 m
Report incorrect company information